StockWatch
·

Concord Drugs Ltd

BSE: 538965

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-13.574.9423.4541.96Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026

Margin Trend

percentage
OPM %NPM %
-116.15-69.49-22.8223.84Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
PeriodQ4 FY2026Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025
INCOME
Revenue35.55+111.1%16.84-28.2%23.46+75.3%13.38+1585.6%0.79-92.6%10.77-9.0%11.84
Other Income0.01-49.1%0.02+783.3%0.000.00-100.0%0.000.01
Total Income35.56+110.9%16.86-28.1%23.46+75.3%13.38+1575.5%0.80-92.6%10.77-9.1%11.85
EXPENSES
Expenditure34.83+110.2%16.57-28.5%23.17+75.1%13.23+66.5%7.95-22.5%10.25-12.9%11.78
Tax0.22+180.8%0.08-3.8%0.08+98.8%0.04+222.2%0.01-95.8%0.30+1395.0%0.02
PROFIT
PBT0.73+150.9%0.29+2.3%0.29+88.3%0.15+102.1%-7.15-1472.2%0.52+604.1%0.07
Net Profit0.52+140.1%0.22+4.7%0.21+84.5%0.11+101.6%-7.16-3326.1%0.22+311.1%0.05
KEY METRICS
OPM %3.99%-1.19pp5.18%-2.51pp7.69%+0.69pp7.00%+107.00pp-100.00%-5.62%
NPM %1.45%+0.17pp1.28%+0.40pp0.88%+0.05pp0.83%+100.83pp-100.00%-102.06pp2.06%+1.60pp0.46%
EPS0.46+187.5%0.16-23.8%0.21+90.9%0.11+37.5%0.08-63.6%0.22+340.0%0.05

Corporate Events

Board MeetingCONCORD
2026
27May

Board Meeting

The board meeting is scheduled to consider and approve the a…

BSE Filing
Board MeetingCONCORD
2025
3Jul

Board Meeting

Increase in Authorised Share Capital and Alteration of Memor…

BSE Filing
Board MeetingCONCORD
2025
19Jun

Board Meeting

Temporarily put on hold the company's proposal to raise fund…

BSE Filing
Board MeetingCONCORD
2025
4Mar

Board Meeting

Proposal to raise funds through a preferential issue of shar…

BSE Filing
Board MeetingCONCORD
2024
6Sep

Board Meeting

Raising of funds for expansion of business and to explore ne…

BSE Filing
Board MeetingCONCORD
2024
25May

Board Meeting

Audited Financial results (standalone & Consolidated) for th…

BSE Filing